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Abstract 
Hematopoietic stem cells (HSC) reside in specialized microenvironments known 
as niches. The niche is essential to support HSC function and to maintain a 
correct balance between self-renewal and differentiation. Recent advances in 
defining different mesenchymal and endothelial bone marrow cell populations as 
well as hematopoietic stem and progenitor cells greatly enhanced our 
understanding of these niches and of the molecular mechanisms by which they 
regulate HSC function. In addition to the role in maintaining HSCs homeostasis, 
the niche has also been implicated in the pathogenesis of blood disorders 
including hematological malignancies. Characterizing the extrinsic regulators and 
the cellular context in which the niches interact with HSCs will be crucial to define 
new strategies to enhance blood regeneration. Furthermore, a better 
understanding of the role of the niche in leukemia development will open new 
possibilities for the treatment of these disorders, by using therapies aiming to 
specifically target the leukemic niche. To update on recent findings on this topic, 
the International Society for Experimental Hematology (ISEH) organized a 
webinar, presented by Prof. Sean J. Morrison and Dr. Simón Méndez-Ferrer and 
moderated by Dr. Cristina Lo Celso, entitled “The evolving view of the 
hematopoietic stem cell niche”, which we summarize here. 
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Introduction 
Continuous production of blood cells is sustained throughout life by a rare 
population of hematopoietic stem cells (HSC), which reside in specialized niches 
mainly in bone marrow (BM) 1. The existence of specific niches or 
microenvironments promoting HSC maintenance was initially proposed by 
Schofield in 1978 2. Already at that time Schofield suggested that stem cells are 
in close association with other tissue-resident cells that prevent stem cell 
differentiation, while ensuring its continuous proliferation. However, only more 
recently advances have been made to determine the location of HSCs and start 
unrevealing the molecular mechanisms by which they are regulated by the niche. 
For this, the finding that SLAM family markers could be used to define HSCs was 
a crucial step, by allowing the identification and purification of these cells to a 
higher purity level and with a simple combination of markers, compatible with 
microscopy analysis 3.  
The BM is a complex network of endothelial cells (including sinusoids, 
arterioles and transition zone vessels) and mesenchymal stromal cells 
(comprising mesenchymal stem and progenitor cells, as well as osteolineage 
cells, chondrocytes and adipocytes) 4-14. Traditionally, two main niches have 
been proposed based on proximity to bone: the endosteal niche in the immediate 
vicinity of bone lining osteoblasts 12, and the vascular niche at a greater distance 
from bone and with a more central localization within BM 3. However, this 
dichotomous view of the niche has been challenged by the fact that the 
endosteal region is also highly vascularized 5. In addition, several studies have 
expanded the number of cell types contributing to the stem cell niche, including 
different endothelial and mesenchymal lineage cell types 3,6,10,15 and also other 
hematopoietic cells such as megakaryocytes 16,17 and macrophages18, as well as 
cells of the sympathetic nervous system 13,19 (Fig 1). Of note, phenotypically 
defined HSCs have been found in close proximity to different putative niche cell 
types, suggesting that different niches supporting different subsets of HSCs may 
exist.  
Here we highlight recent advances in the characterization of the HSC niche by 
summarizing the webinar “The evolving view of the hematopoietic stem cell 
niche”, organized by the International Society for Experimental Hematology 
(ISEH), which was presented on June 14th, 2016 by Prof. Sean J. Morrison and 
Dr. Simón Méndez-Ferrer and moderated by Dr. Cristina Lo Celso. 
 
Sean Morrison: Niche(s) for hematopoietic and osteogenic stem cells in 
adult bone marrow 
The first session, presented by Dr. Sean Morrison, highlighted some of the recent 
developments in defining novel markers of a sinusoidal niche, and the genetic 
tools designed to elucidate the key cells contributing to stem cell maintenance. 
Earlier work by the Morrison group identified HSCs using the “SLAM code” and 
provided a method to characterize and prospectively isolate stem cells using a 
combination of the expression levels of CD150 (SlamF1) CD48, and CD41. 
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Using this combination, they found that long-term HSCs (CD150 high/CD48 
low/CD41low) reside in close proximity to the sinusoidal endothelium, though 
some were also found in the endosteum 3. To further define the niche 
environment, Dr. Morrison’s group developed genetic tools to examine the 
location of critical niche factors, and to explore the effects of conditionally 
deleting these factors. They selected genes previously implicated as niche 
factors important for HSC maintenance, Scf and Cxcl12 12,20,21, together with a 
proposed osteoblast-specific niche factor, Angpt1 22, and generated knock-in 
reporter mice and systematically examined the expression of these factors in the 
bone marrow. 
Rare SCF positive cells reside largely near sinusoids, with some SCF+ cells also 
localizing near arterioles and venuoles. Additionally, the cells expressing the 
highest SCF levels were perivascular stromal cells, while SCF was present only 
at low levels in the endothelial cells. Further characterization of perivascular 
stromal cells expressing high levels of SCF using gene expression profiling 
identified that these cells also express mesenchymal stem/progenitor cell 
markers (Cxcl12, Vcam and Pdgfra-b) in addition to full-length leptin receptor 
(Lepr) 23.  
Lepr+ cells are found primarily near the sinusoids, but are also present near 
small diameter arterioles 24. To establish if these cell populations contained niche 
cells for HSCs, the Morrison group generated a series of genetic models. They 
generated mice with a floxed Scf allele and crossed them to mice with various 
tissue-specific, inducible and constitutive Cre-recombinases (like Lepr-Cre). 
Global deletion of Scf in young adult mice in Ubc-creER;Scffl/fl mice led to a 
significant reduction in bone marrow HSC numbers. This loss of HSC 
maintenance was only reproduced in mice lacking Scf expression in Lepr+ 
perivascular cells or Tie2+ endothelial cells25, whereas no HSC phenotype was 
seen when Scf was deleted specifically in osteoblasts, hematopoietic cells, 
periarteriolar stroma (Nestin-Cre, Nestin-CreER, or Ng2-creER, or 
megakaryocytes. The loss of HSCs due to deletion of Scf in Lepr + cells was 
specific to the adult mice, as no significant change in HSC number was seen in 
the liver of newborn mice, highlighting the different niche environments of HSCs 
during development compared to adulthood. They found similar expression 
patterns of Cxcl12, another known niche factor, with the majority of Cxcl12 
expression localizing to perivascular Lepr+ and endothelial cells. No significant 
effect was seen on the bone marrow HSCs in any of the other tissue-specific 
deletion models tested.  Conditional deletion of Scf in both endothelial and 
LepR+ cells (using Tie2-Cre; Lepr-Cre crossed to floxed alleles) led to significant 
alterations of the stem cell compartment- including loss of HSC number (assayed 
by both immunophenotype and transplant experiments). These mice also have 
truncated life spans, and die of hematopoietic failure due to loss of quiescent 
HSCs. 
Dr. Morrison notes that there may be other critical niche cells that are not 
expressing Scf and Cxcl12, and that there is also a minor fraction of Scf- or 
Cxcl12-expressing cells that are not Lepr+ or endothelial cells. To explore if 
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angiopoietin (Anptl1) might mark some of these niche cells they also 
systematically knocked out Anptl1 ubiquitously or in a tissue-specific manner, but 
were unable to detect an effect on bone marrow HSCs. 
To approach the question of the HSC niche from a different angle, the Morrison 
group wanted to directly visualize the location of the HSCs in the bone marrow. 
They optimized bone-clearing protocols, which replace low refractive 
components within tissue with agents that have higher refractive indexes 26, 
ultimately leading to see-through bones.  Using this technique, the group was 
able to perform high-resolution confocal microscopy to identify stem cell 
locations. As confocal microscopy has limited fluorescence channels compared 
to flow cytometry, the Morrison group identified another HSC marker, α-catulin. 
α-catulin is a relatively un-characterized gene with robust expression largely 
restricted to HSCs and megakaryocyte progenitors in the bone marrow 27 and 
CD45-Tie2+ endothelial cells in neonatal bone marrow 15,26,27. By examining the 
localization of a-catulin/ckit+ cells, Acar et al demonstrated that the vast majority 
of these cells were immediately adjacent to the sinusoidal blood vessels and also 
close to endothelial cells and Lepr+ cells 26.  Though the vast majority of the 
HSCs were found near sinusoidal blood vessels, there were also small numbers 
of HSCs localized to both arterioles and near the transition zone. 
Finally, Dr. Morrison also addressed how other cell types that have been 
implicated in the HSC niche, such as skeletal stem cells, fit into this model. He 
presented data in support of skeletal stem cells in the HSC niche, and further that 
these cells are present in the heterogenous Lepr+ population.  
 
Simon Mendez-Ferrer: The niche in health and disease 
It has become increasingly evident that the niche harboring HSCs consists of a 
complex assembly of multiple niche components existing in close proximity to 
each other. Importantly, changes in cellular composition of the niche, in the 
cytokine/growth factor milieu, or systemic factors produced in response to local 
changes may not only affect the HSCs, but also impact on the other cellular 
components of the microenvironment. Dr. Simon Mendez-Ferrer opened his part 
of the webinar by stressing that it remains to be determined how modulating one 
niche component will in turn impact on the function and HSC supportive capacity 
of the other cell types within the bone marrow microenvironment. He also raised 
the issue that studying the HSC niche and its composition is further complicated 
by the fact that deleting single molecules in single niche cells is not always 
robust. This can be due to redundancy and compensation from other niche cell 
types producing the same niche factor, or inefficient recombination. In line with 
this, the strongest effects on HSCs have been demonstrated in studies using 
constitutive Cre-lines affecting multiple cell types, such as Prx1-Cre and Lepr-Cre 
24,25,28,29
. 
In addition to the early defined niche cells such as osteoblasts, endothelial and 
perivascular cells, Dr. Mendez-Ferrer and colleagues have identified Nestin-GFP 
expressing bone marrow mesenchymal stem cells (BMSCs) to constitute an 
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essential HSC niche component 6. Nestin-GFP+ BMSCs are innervated by the 
sympathetic nervous system, express high levels of HSC maintenance genes, 
and localize with perivascular distribution in very close proximity to HSCs. 
Furthermore, Nestin-GFP+ BMSCs have been shown to be important for HSCs 
homing, and are predicted to regulate HSC traffic under homeostasis 6,19. In a 
recent study, the group of Dr. Mendez-Ferrer demonstrated that some Nestin-
GFP+ BMSCs that provide HSC-supportive function arise from the neural crest, 
and contribute to establishing the HSC niche during prenatal development by 
secreting Cxcl12 30. Depletion of Nestin+ cells at E15.5 greatly reduced the 
migration of HSCs from the fetal liver to the fetal bone marrow 30. Furthermore, 
conditional deletion of Cxcl12 in Nestin+ cells during the first post-natal week 
resulted in 30% reduction of bone marrow HSPCs as measured by long-term 
competitive repopulation assays 30. In contrast, Cxcl12 deletion in adult Nestin+ 
cells does not significantly affect BM HSC numbers 24, probably due to reduced 
recombination efficiency in adult BMSCs and/or compensation by other cell types 
that also produce Cxcl12. The fact that combined Cxcl12 deletion in multiple cell 
types (i.e. those targeted by Prx1-cre, or combined Lepr-cre and Tie2-cre) was 
needed to observe a robust HSC phenotype supports this possibility. However, 
stage-dependent differences might be also influenced by the fact that there are 
different waves of BMSCs during ontogeny which appear to exhibit different 
functions  (30 and summarized in 31). 
Despite different groups stressing the importance of their own favorite niche cell 
types, there is actually more consensus than discrepancies in the field. 
Endothelial and bone marrow stromal cells (BMSCs) (traced using Nestin, Lepr 
and Prx1) constitute important sources of HSC niche factors. However, MSCs 
are heterogeneous with regards to origin, markers and function, and future work 
is needed to dissect the specific subpopulations of niche cells involved, their 
interaction and their specialized functions in HSC regulation. Furthermore, the 
rapid development of single cell techniques has revealed a previously 
unrecognizable heterogeneity in the HSC pool. Hence, it is possible that 
differently primed HSCs or different HSC states require different niches. 
Alternatively, different niches may imprint distinct HSC states. 
It has previously been recognized that malignant hematopoiesis is associated 
with an abnormal microenvironment. However, only in recent years did it become 
apparent that malignant cells and their surrounding niche cells can affect each 
other, and that this bi-directional interaction play a functional role in initiation and 
development of disease 32-39. Myeloproliferative neoplasms (MPNs) are diseases 
caused by mutations in the HSC compartment. Most MPN patients have a 
common acquired mutation of Janus kinase 2 (JAK2) gene in HSCs 40,41, 
resulting in constitutive kinase activity and uncontrolled cell expansion. In a 
recent study Arranz et al. demonstrated that both sympathetic nerve fibers and 
Nestin-GFP+ MSCs were consistently reduced in the bone marrow of MPN 
patients and in mice expressing the human JAK2(V617F) mutation in the HSCs 
32
. Importantly, in vivo depletion of Nestin+ cells accelerated MPN progression, 
whereas administration of neuroprotective or sympathicomimetic drugs improved 
the myelofibrosis associated with this disease 32. This suggests that mutated 
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HSC damage their own niche in MPN and can initiate disease only after 
overcoming niche control. A better understanding of how the niche is modified in 
different hematological disease states could lead to the ability to protect and/or 
treat the niche, and hence be of therapeutic importance. 
 
Concluding remarks: 
Collectively the work presented here highlights the essential role of the HSC 
niche in regulating blood homeostasis and in the development of hematological 
malignancies. This knowledge will be of particular relevance in the regenerative 
medicine field to enhance blood production in patients with impaired 
hematopoiesis, for the ex vivo production/expansion of HSC and mature blood 
cells, and to generate new therapeutics for the treatment of leukemia.   
The full webinar is available online at http://iseh.site-ym.com 
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Figure Legend: 
 
Figure 1. Schematic representation of the bone marrow HSC niche. HSCs have 
been prospectively observed in different BM anatomical locations and in close 
proximity to distinct candidate niche cell types. 
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